The Jerusalem Post‘The fringe didn’t disappear’: Expert explains how to combat online threats, antisemitic propagandaRTP DesportoLiga das Nações. Conferência de imprensa com Jorge Jesus e Bruno FernandesESPNPitt upsets Va. Tech after losing QB; Narduzzi tells pollsters to 'wake ... up'InquirerPublic transport fares rise in E. Visayas amid higher fuel costsPunchJulius Berger begins work on collapsed Delta roadESPN Deportes¿Real Madrid Femenil podrá frenar dominio del Barcelona en Clásico?ZDF heuteEntdecken Sie das ZDF-Nachrichtenstudio3DNewsCapcom сделает RE Engine игровым движком для разработки с помощью ИИIl Fatto QuotidianoUcraina, New York Times: “I negoziatori di Usa e Russia discutono anche di un maxiaffare petrolifero proposto da Putin”VanguardTrump promises $5,000 to every US adult if Republicans win midtermsVarietyZach Bryan Wears ‘Free Palestine’ Shirt While Headlining Robert Kraft’s Gillette Stadium; Drummer Honors Slain Palestinian GirlNOSReuters: belangrijke hacker ShinyHunters aangehouden, werkt samen met FBI
The Daily Newsstand · Free, Always
Saturday, October 3, 2026

Mahama urges Africa to invest in local pharmaceutical manufacturing

Translate

President John Dramani Mahama has urged African countries to accelerate investment in local pharmaceutical manufacturing to reduce the continent’s dependence on imported medicines and vaccines and strengthen its health security.

Speaking at the Health Plenary of the Alamein Africa Forum in Alamein, Egypt, President Mahama said Africa currently imports more than 70 per cent of its pharmaceuticals and nearly 99 per cent of its vaccines.

He said the dependence was resulting in significant foreign exchange outflows while leaving African countries exposed to disruptions in global supply chains.

“Each year, tens of billions of dollars leave our economies to purchase medicines from abroad,” President Mahama said.

He argued that the situation presented not only a challenge but also “a significant market opportunity for domestic capital” as African countries seek to build resilient pharmaceutical industries.

The President identified a growing African market, import substitution, foreign exchange protection and the African Continental Free Trade Area as key pillars of the business case for domestic pharmaceutical production.

He said Africa’s projected population of 2.5 billion by 2050 would create expanding demand for essential medicines, chronic disease management and biologics. Under the AfCFTA, he said, manufacturers could potentially serve a continental market rather than being restricted to individual national markets.

President Mahama also cited the Africa CDC’s first pooled tender for maternal and child health products as evidence of the potential of coordinated African demand.

He said the initiative achieved price reductions of between 30 and 90 per cent while African manufacturers secured 50 per cent of the product lines.

“Coordinated demand guarantees cash flows for producers,” he said, calling on bankers, institutional investors and industrial leaders to support pharmaceutical manufacturing as a resilient area for investment.

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.

Tags:  

DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.

View the original on MyJoyOnline →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.